Variants in DNA double-strand break repair genes and risk of familial breast cancer in a South American population
Author
dc.contributor.author
Jara, Lilian
Author
dc.contributor.author
Dubois, Karen
Author
dc.contributor.author
Gaete, Daniel
Author
dc.contributor.author
De Mayo, Tomas
Author
dc.contributor.author
Ratkevicius, Nikalai
Author
dc.contributor.author
Bravo, Teresa
Author
dc.contributor.author
Margarit, Sonia
Author
dc.contributor.author
Blanco, Rafael
Author
dc.contributor.author
Gómez, Fernando
Author
dc.contributor.author
Waugh, Enrique
Author
dc.contributor.author
Peralta, Octavio
Author
dc.contributor.author
Reyes, Jose M.
Author
dc.contributor.author
Ibáñez, Gladys
Author
dc.contributor.author
González Hormazábal, Patricio
Admission date
dc.date.accessioned
2019-03-11T13:00:10Z
Available date
dc.date.available
2019-03-11T13:00:10Z
Publication date
dc.date.issued
2010
Cita de ítem
dc.identifier.citation
Breast Cancer Research and Treatment, Volumen 122, Issue 3, 2018, Pages 813-822
Identifier
dc.identifier.issn
15737217
Identifier
dc.identifier.issn
01676806
Identifier
dc.identifier.other
10.1007/s10549-009-0709-2
Identifier
dc.identifier.uri
https://repositorio.uchile.cl/handle/2250/165047
Abstract
dc.description.abstract
The double-strand break (DSB) DNA repair pathway has been implicated in breast cancer (BC). RAD51 and its paralogs XRCC3 and RAD51D play an important role in the repair of DSB through homologous recombination (HR). Some polymorphisms including XRCC3-Thr241Met, RAD51-135G>C, and RAD51D-E233G have been found to confer increased BC susceptibility. In order to detect novel mutations that may contribute to BC susceptibility, 150 patients belonging to 150 Chilean BRCA1/2-negative families were screened for mutations in XRCC3. No mutations were detected in the XRCC3 gene. In addition, using a case-control design we studied the XRCC3-Thr241Met, and RAD51D-E233G polymorphisms in 267 BC cases and 500 controls to evaluate their possible association with BC susceptibility. The XRCC3 Met/Met genotype was associated with an increased BC risk (P = 0.003, OR = 2.44 [95%CI 1.34-4.43]). We did not find an association between E233G polymorphism and BC risk. We also analyzed the effect of combined genotyp